Good afternoon, and welcome to the Harvest Health & Recreation conference call to review second quarter 2021 financial and operating results and discuss the company's performance outlook. At this time, all participants will be in a listen-only mode. The call will begin with prepared comments by management. There will not be a question and answer session. Today's conference call is being recorded. I would now like to turn the conference over to your host, Christine Hersey, Director of Investor Relations for Harvest. Thank you. You may begin. Thank you. Good afternoon, everyone, and welcome to Harvest second quarter 2021 earnings call. Today's call will include remarks from Harvest founder and Chief Executive Officer, Steve White. These remarks may include forward-looking statements, which are subject to various risks and uncertainties that could cause our actual results to differ materially from these statements. These risks and uncertainties are detailed in the company's reports filed with the United States Securities and Exchange Commission and Canadian securities regulators, including our annual report on Form 10-K, which was filed on March 30th, 2021, and in each of our quarterly reports on Form 10-Q. Our quarterly report for June 30th, 2021, when filed this week, along with today's earnings press release and a PowerPoint presentation, can be found under the Investors section of our website. Harvest assumes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise following today's call. Throughout the discussion, Harvest will refer to adjusted EBITDA, which is a non-GAAP financial measure. A reconciliation of adjusted EBITDA to the most directly comparable GAAP measure is included in our earnings press release and SEC and SEDAR filings. Please note, all financial information is provided in US dollars unless otherwise indicated. I'll now turn the call over to Steve White, Harvest founder and Chief Executive Officer. Please go ahead. Thanks, Christine. Good afternoon, everyone, and thank you for joining us. I appreciate your continued support and interest in Harvest. Before we review our second quarter results, I will provide a brief update on Trulieve's pending acquisition of Harvest. For those of you who may not be aware, the pending sale was previously announced on May 10th, 2021. Details regarding the transaction are outlined in regulatory filings with the SEC and with SEDAR. Since the deal was announced, both companies have made significant progress towards meeting closing conditions and obtaining necessary regulatory approvals required to complete the transaction. On June 22nd, Trulieve announced that the HSR Act waiting period expired. Following the completion of this milestone, both companies immediately began integration activities in anticipation of closing. To date, integration planning and preparation for combining the two organizations has gone smoothly. The Harvest shareholder vote for the proposed transaction is being held tomorrow, August 11th, as part of the Harvest annual and special shareholder meeting. In parallel to the integration efforts, both companies have been working hard to secure required state and local regulatory approvals to transfer ownership and operation of existing Harvest assets to Trulieve. While we cannot provide an exact time when those regulatory approvals may be complete, the collaboration to date adds further excitement about the prospects for the combined organization moving forward, and we appreciate shareholder support of the business combination. Now turning to our results. Second quarter sales of $102.5 million represents an 84% increase year-over-year and a 15% increase from the first quarter. Approximately 89% of our second quarter revenue is derived from our core markets, Arizona, Florida, Maryland, and Pennsylvania. Revenue derived from core markets excluding Florida was 83%. Revenue mix during the second quarter was 83% retail and 17% wholesale and other. Second quarter same-store sales increased by 100% year-over-year for the 32 stores that were open during both periods. For the 36 stores that were open in both the first and second quarters of 2021, same-store sales increased by 11% sequentially. During the second quarter, traffic increased by 22%, while basket size declined 9% compared to the first quarter. In the second quarter, revenue growth was driven by the full quarter contribution of recreational sales in Arizona, growth in new and existing locations company-wide, and contribution from cultivation and manufacturing expansion activities. In Arizona, as expected, Harvest recreational sales continue to grow as a percentage of total cannabis sales. During the second quarter, we added five new retail locations and continued our expansion activities at several cultivation and manufacturing facilities. Subsequent to year-end, we opened two new retail locations. As of August 10th, Harvest owned, operated, or managed 44 retail locations in five states, including 16 open dispensaries in Arizona. Gross margin during the second quarter was 51%, compared to 53.9% during the first quarter of 2021. The sequential decline in gross margin was driven primarily by increased promotional activity and higher prices for select third-party products. Promotional activity was higher in the quarter in several markets due to sales associated with April 20, and promotional activity was higher in our home state of Arizona as more dispensaries expanded to include recreational sales. SG&A was $34.6 million, or 33.7% of revenue during the second quarter. Higher professional fees and expenses, including transaction costs associated with the pending Trulieve transaction, as well as increased salaries and wages associated with our increased employee count, contributed to the sequential increase in SG&A expenses. Net loss before non-controlling interest for the second quarter was $19.2 million. Net loss includes the impact of an $8.4 million expense associated with the fair value of warrant liability. This non-cash charge was driven by stock price movement during the quarter. We cannot predict the impact of this accounting treatment for our outstanding warrants each quarter, but we note that it is not a reflection of our underlying business. At the end of the second quarter, we converted the currency of select outstanding warrants to US dollars from Canadian dollars, which will result in the classification of those warrants as equity for the third quarter and moving forward. We expect this change will significantly decrease the impact of fair value warrant liability measurements to our income statement in future reporting periods. Our second quarter adjusted EBITDA increased to $28 million or 26% of revenue, compared to $26.9 million or 30% of revenue during the first quarter of 2021. Harvest ended the second quarter of 2021 with approximately $71 million in cash and $279 million in debt. Subsequent to quarter end, Harvest divested non-core cultivation and processing assets in Utah for an immaterial amount of cash and completed the conversion of $10 million in convertible debt due December 2021 to equity. During the three months ended June 2021, we spent approximately $17.6 million on capital expenditures, with the majority of the investments made in our core markets, Arizona, Florida, Maryland, and Pennsylvania. In our home state of Arizona, we have 16 locations serving both medical patients and recreational customers. Our 17th and 18th locations will open in the near term, pending regulatory approvals. We expect to have a 19th location starting in 2023, when a current licensing agreement expires in May of that year. Our retail locations are supported by cultivation facilities in Camp Verde, El Mirage, Phoenix, and Willcox, and processing and manufacturing facilities in Flagstaff and Phoenix. We are expanding cultivation and processing operations in Arizona to provide greater supply to our retail locations. We expect continued strength in the Arizona market as new customers continue to learn about and embrace legal and regulated cannabis products. Our other three core markets all have future potential upside from recreational cannabis consumption. In Florida, we have 11 open retail locations, including five new locations opened since May. We are continuing to expand our cultivation and manufacturing capacity with new product and store openings coming into the market in 2021. In Maryland, we currently have three open retail dispensaries and a cultivation and processing facility. Harvest is a net wholesaler in the state of Maryland, with strong sales outside of our retail operations. We are expanding our cultivation and manufacturing operations in Hancock, Maryland to support our wholesale business and retail locations. In Pennsylvania, Harvest currently operates 10 retail dispensaries and a cultivation and processing facility. Harvest has five retail licenses, allowing for up to 15 potential retail locations. We are expanding cultivation and manufacturing operations to enhance margins and support the opening of additional retail locations in 2021. Now turning to our 2021 outlook. At this time, we're not adjusting our 2021 full year revenue target of at least $400 million. Since the start of the COVID pandemic, we've followed CDC, state, and local guidelines at all of our facilities, and recently, we have reinstated heightened COVID safety measures as recommended at our facilities to protect our employees, patients, and our customers. It is due to the lack of visibility and difficulty of predicting the impact of COVID on retail performance, or patient and consumer behavior, that we are leaving our 2021 revenue target unchanged at this time. The 2021 revenue target implies continued growth driven by recreational sales in Arizona, same-store sales growth, new retail dispensary openings, and expanded cultivation and manufacturing operations. While we expect gross margins will continue to fluctuate quarterly due to levels of promotional activity, product and market mix, and the cost of third-party products, we expect our reported gross margins will remain at or above 50%. Debt service for the remainder of the year is approximately $34 million, including the $10 million convertible debt that was converted to equity after the end of the second quarter. Capital expenditures for the remainder of the year are expected to range between $20 million and $35 million and may be expanded or accelerated depending on the availability of financing. Capital expenditures for the full year are expected to be between $45 million and $60 million, up from our prior target of $35 million-$45 million, and higher than 2020 capital expenditures of $26.9 million. We are pleased with the progress that we've made over the past several quarters. We look forward to continuing to build on this momentum as we prepare to complete the merger with Trulieve. We believe the combined organization will be very well positioned to capitalize on growth opportunities for years to come. This will conclude our earnings call today. Thank you. This does conclude today's conference call. Thank you for participating. You may now disconnect.